Skip to main content

Table 1 Univariate and multivariate Cox regression analysis of LINC01133 and survival in patients with gastric cancer

From: LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway

Clinical variables

Univariate analysis

P value

Multivariate analysis

P value

HR

95% CI

HR

95% CI

Overall Survival

 Gender (Male vs. Female)

0.776

0.500–1.203

0.257

   

 Age (≥60y vs. <60y)

0.978

0.639–1.496

0.918

   

 Tumor location (Down vs. Upper/Middle)

0.784

0.512–1.199

0.261

   

 Tumor size (≥5 cm vs. < 5 cm)

1.413

0.913–2.185

0.121

   

 Differentiation (Poor vs. Moderate/Well)

1.855

0.960–3.587

0.066

   

 T stage (T3-T4 vs. T1-T2)

4.126

1.512–11.259

0.006

   

 N stage (N2-N3 vs. N0-N1)

2.117

1.304–3.436

0.002

   

 TNM stage (III-IV vs. II-I)

3.756

2.040–6.918

< 0.001

2.637

1.405–4.951

0.003

 Distant metastasis (Yes vs. No)

3.533

2.061–6.059

< 0.001

2.133

1.227–3.706

0.007

 Infiltration of peritumoral tissues (Yes vs. No)

2.521

1.646–3.862

< 0.001

1.956

1.269–3.014

0.002

 Peritoneum dissemination (Yes vs. No)

3.725

1.958–7.084

< 0.001

   

 LINC01133 expression (high vs. low)

0.381

0.244–0.597

< 0.001

0.517

0.328–0.815

0.005

Progression-Free Survival

 Gender (Male vs. Female)

0.812

0.518–1.273

0.364

   

 Age (≥60y vs. <60y)

0.805

0.518–1.250

0.333

   

 Tumor location (Down vs. Upper/Middle)

0.722

0.468–1.114

0.141

   

 Tumor size (≥5 cm vs. < 5 cm)

1.210

0.782–1.872

0.391

   

 Differentiation (Poor vs. Moderate/Well)

1.127

0.635–2.001

0.682

   

 T stage (T3-T4 vs. T1-T2)

5.979

1.887–18.945

0.002

   

 N stage (N2-N3 vs. N0-N1)

2.419

1.463–4.000

0.001

   

 TNM stage (III-IV vs. II-I)

3.511

1.941–6.351

< 0.001

2.493

1.352–4.595

0.003

 Distant metastasis (Yes vs. No)

3.052

1.706–5.459

< 0.001

1.855

1.024–3.360

0.042

 Infiltration of peritumoral tissues (Yes vs. No)

2.381

1.532–3.699

< 0.001

1.792

1.146–2.802

0.011

 Peritoneum dissemination (Yes vs. No)

2.210

1.010–4.835

0.047

   

 LINC01133 expression (high vs. low)

0.345

0.217–0.547

< 0.001

0.460

0.287–0.736

0.001

  1. NOTE: TNM tumour node metastasis. HR hazard ratio, CI confidence interval. The bold type represents P values smaller than 0.05